Back

Mechanisms and models of anti-cancer drugs.

1 September 2019 (12:07 - 12:30)
Organised by:
Congress Presentation Part of: Cardio-Oncology: Novel mechanisms and clinical implications Basic Science, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Alessandra Ghigo

University of Turin, Turin (Italy)

3 More presentations in this session

Presentation thumbnail
The failing heart stimulates tumor growth by circulating factors
Professor R. De Boer (Rotterdam, NL)
Slides Video
Presentation thumbnail
Inflammation as a common risk factor for cancer and cardiovascular disease.
Professor P. Libby (Boston, US)
Slides Video
Presentation thumbnail
Cardiovascular side effects of anti-tumor drugs.
Doctor J. Moslehi (San Francisco, US)
Slides Video

Access the full session

Session thumbnail
Cardio-Oncology: Novel mechanisms and clinical implications

The Event

Event poster

ESC Congress 2019

1 September 2019 12:07 CET
You may be interested in
thumbnail
Congress Session
New insights into cancer therapy-related cardiac dysfunction
18 May 2025
thumbnail
Congress Presentation
Cardioprotective effects of the flavonoid quercetin against doxorubicin-Induced cardiotoxicity in H9c2 cardiomyoblasts
20 June 2025
thumbnail
Congress Presentation
The new mechanism of apatinib in treating gastric cancer-related hypertension: dynamin-related protein 1-mediated pathological mitochondrial fission in endothelial cells
1 September 2025
thumbnail
Congress Presentation
Incidence of drug-drug interactions of QT-prolonging drugs in an onco-hematological outpatient
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources